Episode 13: Advances in MASLD and MASH
Listen now
Description
Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.
More Episodes
Prof. Giacomo Grasselli takes us through the new concepts and explains why defining ARDS is such a difficult proposition.
Published 07/05/24
Published 07/05/24
Dr. Eduard Shantsila discusses rehabilitation approaches for complex patients with heart disease and comorbid frailty, including those with cognitive vulnerability.
Published 05/24/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
